Appendix 2—table 26. Statin User Cohort (All Regions) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| All Statin Users by BP: Unmatched | All Statin Users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 1,436,300 | 100.0% | 1,218,319 | 84.8% | 217,981 | 15.2% | 426,960 | 100.0% | 213,480 | 50.0% | 213,480 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 1,385 | 0.1% | 1,365 | 0.1% | 20 | 0.0% | <0.001 | 42 | 0.0% | 22 | 0.0% | 20 | 0.0% | 1.00 |
| 21-40 | 44,389 | 3.1% | 44,042 | 3.6% | 347 | 0.2% | 704 | 0.2% | 357 | 0.2% | 347 | 0.2% | ||
| 41-50 | 135,867 | 9.5% | 133,850 | 11.0% | 2,017 | 0.9% | 4,033 | 0.9% | 2,016 | 0.9% | 2,017 | 0.9% | ||
| 51-60 | 356,032 | 24.8% | 333,325 | 27.4% | 22,707 | 10.4% | 45,439 | 10.6% | 22,732 | 10.6% | 22,707 | 10.6% | ||
| 61-70 | 428,943 | 29.9% | 356,208 | 29.2% | 72,735 | 33.4% | 144,861 | 33.9% | 72,341 | 33.9% | 72,520 | 34.0% | ||
| 71-80 | 302,081 | 21.0% | 223,651 | 18.4% | 78,430 | 36.0% | 150,527 | 35.3% | 75,316 | 35.3% | 75,211 | 35.2% | ||
| ≥81 | 167,603 | 11.7% | 125,878 | 10.3% | 41,725 | 19.1% | 81,354 | 19.1% | 40,696 | 19.1% | 40,658 | 19.0% | ||
| Gender | ||||||||||||||
| Female | 843,147 | 58.7% | 646,846 | 53.1% | 196,301 | 90.1% | <0.001 | 383,586 | 89.8% | 191,786 | 89.8% | 191,800 | 89.8% | 0.94 |
| Male | 593,153 | 41.3% | 571,473 | 46.9% | 21,680 | 9.9% | 43,374 | 10.2% | 21,694 | 10.2% | 21,680 | 10.2% | ||
| Region | ||||||||||||||
| Midwest | 271,319 | 18.9% | 237,718 | 19.5% | 33,601 | 15.4% | <0.001 | 67,050 | 15.7% | 33,525 | 15.7% | 33,525 | 15.7% | 1.00 |
| Northeast | 423,934 | 29.5% | 366,936 | 30.1% | 56,998 | 26.1% | 113,308 | 26.5% | 56,654 | 26.5% | 56,654 | 26.5% | ||
| South | 523,112 | 36.4% | 442,996 | 36.4% | 80,116 | 36.8% | 157,838 | 37.0% | 78,919 | 37.0% | 78,919 | 37.0% | ||
| West | 217,935 | 15.2% | 170,669 | 14.0% | 47,266 | 21.7% | 88,764 | 20.8% | 44,382 | 20.8% | 44,382 | 20.8% | ||
| Insurance | ||||||||||||||
| Commercial | 587,625 | 40.9% | 533,843 | 43.8% | 53,782 | 24.7% | <0.001 | 107,552 | 25.2% | 53,774 | 25.2% | 53,778 | 25.2% | 1.00 |
| Dual | 55,356 | 3.9% | 42,041 | 3.5% | 13,315 | 6.1% | 24,380 | 5.7% | 12,183 | 5.7% | 12,197 | 5.7% | ||
| Medicaid | 320,911 | 22.3% | 280,799 | 23.0% | 40,112 | 18.4% | 76,121 | 17.8% | 38,050 | 17.8% | 38,071 | 17.8% | ||
| Medicare | 472,408 | 32.9% | 361,636 | 29.7% | 110,772 | 50.8% | 218,907 | 51.3% | 109,473 | 51.3% | 109,434 | 51.3% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 507,726 | 35.3% | 430,446 | 35.3% | 77,280 | 35.5% | 0.27 | 151,395 | 35.5% | 75,614 | 35.4% | 75,781 | 35.5% | 0.59 |
| Yes | 928,574 | 64.7% | 787,873 | 64.7% | 140,701 | 64.5% | 275,565 | 64.5% | 137,866 | 64.6% | 137,699 | 64.5% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.11 | 1.75 | 1.13 | 1.77 | 0.95 | 1.66 | <0.001 | 0.97 | 1.66 | 0.97 | 1.66 | 0.97 | 1.67 | 0.79 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.